Culp Elizabeth J, Sychantha David, Hobson Christian, Pawlowski Andrew C, Prehna Gerd, Wright Gerard D
M.G. DeGroote Institute for Infectious Disease Research, David Braley Centre for Antibiotic Discovery, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.
Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Nat Microbiol. 2022 Mar;7(3):451-462. doi: 10.1038/s41564-022-01073-4. Epub 2022 Mar 4.
The caseinolytic protease (ClpP) is part of a highly conserved proteolytic complex whose disruption can lead to antibacterial activity but for which few specific inhibitors have been discovered. Specialized metabolites produced by bacteria have been shaped by evolution for specific functions, making them a potential source of selective ClpP inhibitors. Here, we describe a target-directed genome mining strategy for discovering ClpP-interacting compounds by searching for biosynthetic gene clusters that contain duplicated copies of ClpP as putative antibiotic resistance genes. We identify a widespread family of ClpP-associated clusters that are known to produce pyrrolizidine alkaloids but whose connection to ClpP has never been made. We show that previously characterized molecules do not affect ClpP function but are shunt metabolites derived from the genuine product of these gene clusters, a reactive covalent ClpP inhibitor. Focusing on one such cryptic gene cluster from Streptomyces cattleya, we identify the relevant inhibitor, which we name clipibicyclene, and show that it potently and selectively inactivates ClpP. Finally, we solve the crystal structure of clipibicyclene-modified Escherichia coli ClpP. Clipibicyclene's discovery reveals the authentic function of a family of natural products whose specificity for ClpP and abundance in nature illuminate the role of eco-evolutionary forces during bacterial competition.
酪蛋白水解蛋白酶(ClpP)是一种高度保守的蛋白水解复合物的一部分,其破坏可导致抗菌活性,但针对它的特异性抑制剂却很少被发现。细菌产生的特殊代谢产物在进化过程中形成了特定功能,使其成为选择性ClpP抑制剂的潜在来源。在这里,我们描述了一种靶向基因组挖掘策略,通过搜索包含ClpP重复拷贝作为假定抗生素抗性基因的生物合成基因簇来发现与ClpP相互作用的化合物。我们鉴定出一个广泛存在的与ClpP相关的基因簇家族,已知该家族产生吡咯里西啶生物碱,但此前从未建立起它们与ClpP的联系。我们表明,先前表征的分子并不影响ClpP功能,而是这些基因簇真正产物的分流代谢物,即一种具有反应性的共价ClpP抑制剂。聚焦于来自卡特利链霉菌的一个这样的隐秘基因簇,我们鉴定出了相关抑制剂,将其命名为clipibicyclene,并表明它能有效且选择性地使ClpP失活。最后,我们解析了clipibicyclene修饰的大肠杆菌ClpP的晶体结构。Clipibicyclene的发现揭示了一类天然产物的真实功能,它们对ClpP的特异性以及在自然界中的丰度揭示了细菌竞争过程中生态进化力量的作用。